Table 3.
Group/n 20th/40th week | Control 4/4 | TMX 4/4 | RLX 4/4 | p (ANOVA) |
---|---|---|---|---|
TCV (mm³) 20th/40th week | 15.65 ± 0.89/15.53 ± 1.8 | 16.41 ± 3.38/14.57 ± 1.36 | 14.36 ± 3.63/11.43 ± 1.7 | 0.619/0.016 |
TTV (mm³) 20th/40th week | 5.14 ± 0.53/5.13 ± 1.26 | 5.21 ± 0.98/6.79 ± 0.93 | 4.82 ± 1.5/4.68 ± 0.70 | 0.868/0.034 |
%TTV/TCV 20th/40th week | 32.99 ± 4.59/31.53 ± 6.03 | 31.86 ± 1.81/47.09 ± 8.67 | 34.07 ± 7.27/41.31 ± 6.74 | 0.83/0.04 |
TDV (mm³) 20th/40th week | 2.71 ± 0.27/2.96 ± 0.58 | 2.06 ± 0.74/2.62 ± 0.43 | 2.05 ± 0.35/1.99 ± 0.27 | 0.157/0.038 |
TNPV(mm³) 20th/40th week | 0.54 ± 0.19/0.48 ± 0.28 | 0.32 ± 0.14/0.52 ± 0.16 | 0.30 ± 0.13/0.40 ± 0.85 | 0.114/0.703 |
TGPV (mm³) 20th/40th week | 0.68 ± 0.06/0.59 ± 0.14 | 0.38 ± 0.12/0.48 ± 0.09 | 0.38 ± 0.13/0.46 ± 0.06 | 0.005/0.198 |
The p groups provided in the table are for ANOVA test of all groups and significant figures are presented in bold
TCV Total corpus volume, TTV Total trabecular volume, TDV Total disc volume, TNPV Total nucleus pulposus volume, TGPV Total growth plate volume